Effect of tibolone therapy on lipids and coagulation indices.
Daher
Rose
R
Al-Amin
Hadi
H
Beaini
Mona
M
Usta
Ihab
I
D000990:Antithrombin III / Q000032:analysis; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000032:analysis*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D020847:Estrogen Receptor Modulators / Q000494:pharmacology; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006710:Homocysteine / Q000097:blood; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects*; D008055:Lipids / Q000097:blood*; D017270:Lipoprotein(a) / Q000097:blood; D008875:Middle Aged; D009652:Norpregnenes / Q000494:pharmacology*; D017698:Postmenopause / Q000097:blood; D011446:Prospective Studies; D011486:Protein C / Q000032:analysis; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood
D001779:Blood Coagulation Factors; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D020847:Estrogen Receptor Modulators; D008055:Lipids; D017270:Lipoprotein(a); D009652:Norpregnenes; D011486:Protein C; D014280:Triglycerides; D006710:Homocysteine; D000990:Antithrombin III; D005340:Fibrinogen; D002784:Cholesterol; C027385:tibolone